The Online Books Page

Clinical medicine -- Research -- United States

See also what's at your library, or elsewhere.

• Clinical medicine -- Research
• Medicine -- Research -- United States
• Clinical medicine -- United States
• Research -- United States

• Clinical medicine -- United States -- Research

• Clinical medicine -- Research -- United States -- Congresses
• Clinical medicine -- Research -- United States -- Directories
• Clinical trials -- United States

• Becoming a patient at the National Institutes of Health, Clinical Center. (Clinical Center, National Institutes of Health, 1995), by National Institutes of Health (U.S.). Clinical Center (page images at HathiTrust)
• Support strategies for clinical research and alternative medicine research at the NIH : hearing before the Subcommittee on Public Health and Safety of the Committee on Labor and Human Resources, United States Senate, One Hundred Fifth Congress, first session ... Oct. 9, 1997. (U.S. G.P.O. :, 1998), by United States. Congress. Senate. Committee on Labor and Human Resources. Subcommittee on Public Health and Safety (page images at HathiTrust)
• The Clinical Pathology Department at the National Institutes of Health. (Clinical Center, U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, 1994), by National Institutes of Health (U.S.). Clinical Center (page images at HathiTrust)

• Quality of life in clinical cancer trials : proceedings of a workshop held at the National Institutes of Health, Bethesda, Maryland, March 1-2, 1995 (National Cancer Institute ;, 1996), by National Cancer Institute (U.S.). Division of Cancer Prevention and Control and Diagnosis National Cancer Institute (U.S.). Division of Cancer Treatment (page images at HathiTrust)

• Quality of life in clinical cancer trials : proceedings of a workshop held at the National Institutes of Health, Bethesda, Maryland, March 1-2, 1995 (National Cancer Institute ;, 1996), by National Cancer Institute (U.S.). Division of Cancer Prevention and Control and Diagnosis National Cancer Institute (U.S.). Division of Cancer Treatment (page images at HathiTrust)

• National Cancer Institute Economic Conference, the Integration of Economic Outcome Measures into NCI-Sponsored Therapeutic Trials : proceedings of a workshop held at the National Institutes of Health, Bethesda, Maryland, April 20-22, 1994 (The Institute ;, 1995), by National Cancer Institute Economic Conference: the Integration of Economic Outcome Measures into NCI-Sponsored Therapeutic Trials (1994 : National Institutes of Health), Georgetown University. Medical Center. Clinical Economics Research Unit, and National Cancer Institute (U.S.) (page images at HathiTrust)

• Statistical issues in clinical trials for treatment of opiate dependence (U.S. Dept. of Health and Human Services, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute on Drug Abuse ;, 1992), by Ram B. Jain and National Institute on Drug Abuse (page images at HathiTrust)

• General clinical research centers (National Institutes of Health, Division of Research Resources, 1978), by National Institutes of Health (U.S.). Division of Research Resources, National Center for Research Resources (U.S.), and Research Resources Information Center (page images at HathiTrust)

• The Impact of Randomized Clinical Trials on Health Policy and Medical Practice: Background Paper (Washington: Office of Technology Assessment, 1983), by Hellen Gelband, contrib. by Thomas Chalmers and Henry Sacks
  • page images at HathiTrust
  • PDF files at Princeton
• What are clinical trials all about? (U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, 1995), by National Institutes of Health (U.S.) (page images at HathiTrust)
• New drug development in the United States (Dept. of Health & Human Services, Public Health Service, Food and Drug Administration, 1995), by United States Food and Drug Administration (page images at HathiTrust)
• Problems in securing informed consent of subjects in experimental trials of unapproved drugs and devices : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, second session, Washington, DC, May 23, 1994. (U.S. G.P.O. :, 1994), by Business Opportunities United States. Congress. House. Committee on Small Business. Subcommittee on Regulation (page images at HathiTrust)
• National Institute of Health clinical trials (The Office, 1999), by United States General Accounting Office (page images at HathiTrust)
• Internal controls are key to safeguarding Phase III trials against misconduct (The Office ;, 1996), by United States General Accounting Office (page images at HathiTrust)
• Clinical research : hearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Fourth Congress, second session, special hearing. (U.S. G.P.O. :, 1996), by Health and Human Services United States. Congress. Senate. Committee on Appropriations. Subcommittee on Departments of Labor (page images at HathiTrust)
• Harnessing science : advancing care by accelerating the rate of cancer clinical trial participation : hearing before the Committee on Government Reform, House of Representatives, One Hundred Eighth Congress, second session, May 13, 2004. (U.S. G.P.O. :, 2004), by United State House Committee on Government Reform (page images at HathiTrust)
• Protections for foster children enrolled in clinical trials : hearing before the Subcommittee on Human Resources of the Committee on Ways and Means, U.S. House of Representatives, One Hundred Ninth Congress, first session, May 18, 2005. (U.S. G.P.O. :, 2007), by United States. Congress. House. Committee on Ways and Means. Subcommittee on Human Resources (page images at HathiTrust)
• From test tube to patient : new drug development in the United States. (Dept. of Health & Human Services, Public Health Service, Food and Drug Administration, 1990), by United States Food and Drug Administration (page images at HathiTrust)
• Clinical trials of medical treatments (Dept. of Health and Human Services, Food and Drug Administration, 2001), by United States Food and Drug Administration (page images at HathiTrust)
• Adequacy of access to investigative drugs for seriously ill patients : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, first session, September 23, 1997. (U.S. G.P.O. :, 1997), by United States House Committee on Commerce, Subcommittee on Oversight and Investigations (page images at HathiTrust)
• Improper Medicare billing by hospitals nationwide for investigational devices and procedures : hearing before the Permanent Subcommittee on Investigations of the Committee on Governmental Affairs, United States Senate, One Hundred Fourth Congress, second session, February 14, 1996. (U.S. G.P.O. :, 1996), by United States. Congress. Senate. Committee on Governmental Affairs. Permanent Subcommittee on Investigations (page images at HathiTrust)
• Investigator's handbook : a manual for participants in clinical trials of investigational agents sponsored by the Division of Cancer Treatment, National Cancer Institute. (Cancer Therapy Evaluation Program, Division of Cancer Treatment, National Cancer Institute, 1987), by National Cancer Institute (U.S.). Cancer Therapy Evaluation Program (page images at HathiTrust)
• Clinical trial subjects : adequate FDA protections? : hearing before the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, second session, April 22, 1998. (U.S. G.P.O. :, 1998), by United States. Congress. House. Committee on Government Reform and Oversight (page images at HathiTrust)
• Institutional review boards, a system in jeopardy : hearing before the Subcommittee on Human Resources of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fifth Congress, second session, June 11, 1998. (U.S. G.P.O. :, 1999), by United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources (page images at HathiTrust)
• Competitive problems in the drug industry : drug testing : summary and analysis, Select Committee on Small Business, United States Senate (U.S. Govt. Print. Off. :, 1979), by Library of Congress. Congressional Research Service and United States. Congress. Senate. Select Committee on Small Business (page images at HathiTrust)
• Deadly diseases and people of color (U.S. Food and Drug Administration, 1996), by Howard University. School of Continuing Education, Maryland AIDS Professional Education Center, and United States Food and Drug Administration (page images at HathiTrust)
• Estudios para la prevención del cáncer : lo que los participantes deben saber (Institutos Nacionales de la Salud, Instituto Nacional del Cáncer, 2000), by National Cancer Institute (U.S.) (page images at HathiTrust)
• FDA and the reform of the medical device approval process (U.S. G.P.O. :, 2011), by United States Senate Special Committee on Aging (page images at HathiTrust)
• En qué consisten los estudios clínicos? : un folleto para los pacientes de cáncer (Institutos Nacionales de la Salud, Instituto Nacional del Cáncer, 1995), by National Cancer Institute (U.S.) (page images at HathiTrust)
• Lo que los pacientes de cáncer deben saber (Institutos Nacionales de la Salud, Instituto Nacional del Cáncer, 2000), by National Cancer Institute (U.S.) (page images at HathiTrust)

• An Integrated oncology workstation : final report (National Cancer Institute, NIH, 1992), by Edward Hance Shortliffe, Stanford University. School of Medicine, and National Cancer Institute (U.S.) (page images at HathiTrust)

• The regulation of new drugs by the Food and Drug Administration : the new drug review process : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-seventh Congress, second session, August 3 and 4, 1982. (U.S. G.P.O. :, 1982), by United States. Congress. House. Committee on Government Operations. Intergovernmental Relations and Human Resources Subcommittee (page images at HathiTrust)

• Ketek clinical study fraud : what did Aventis know? : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, February 12, 2008. (U.S. G.P.O. :, 2008), by United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations (page images at HathiTrust)

• Current issues in human subject protection : an FDA perspective : September 13, 1996, Natcher Auditorium. (Food and Drug Administration, 1996), by United States Food and Drug Administration (page images at HathiTrust)
• Clinical trials in developing countries (National Bioethics Advisory Commission, 2001), by United States. National Bioethics Advisory Commission (page images at HathiTrust)
• Human subject research protections : hearing before the Subcommittee on Criminal Justice, Drug Policy, and Human Resources of the Committee on Government Reform, House of Representatives, One Hundred Sixth Congress, second session, May 3, 2000. (U.S. G.P.O. :, 2001), by Drug Policy United States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice (page images at HathiTrust)
• Protecting human subjects in research : are current safeguards adequate? : hearing before the Subcommittee on Public Health of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Seventh Congress, second session, on examining current safeguards concerning the protection of human subjects in research, while facilitating critical medical research, April 23, 2002. (U.S. G.P.O. :, 2002), by Education United States. Congress. Senate. Committee on Health (page images at HathiTrust)

• Gene therapy : is there oversight for patient safety? : hearing before the Subcommittee on Public Health of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Sixth Congress, second session ... February 2, 2000. (U.S. G.P.O. :, 2000), by Education United States. Congress. Senate. Committee on Health (page images at HathiTrust)
• Gene therapy : are patients any safer? : hearing before the Subcommittee on Public Health of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Sixth Congress, second session ... May 25, 2000. (U.S. G.P.O. :, 2000), by Education United States. Congress. Senate. Committee on Health (page images at HathiTrust)

Items below (if any) are from related and broader terms.

• Internal controls are key to safeguarding Phase III trials against misconduct (The Office ;, 1996), by United States General Accounting Office (page images at HathiTrust)
• Support strategies for clinical research and alternative medicine research at the NIH : hearing before the Subcommittee on Public Health and Safety of the Committee on Labor and Human Resources, United States Senate, One Hundred Fifth Congress, first session ... Oct. 9, 1997. (U.S. G.P.O. :, 1997), by United States. Congress. Senate. Committee on Labor and Human Resources. Subcommittee on Public Health and Safety (page images at HathiTrust)

• Testing Treatments: Better Research for Better Healthcare (second edition; London: Pinter and Martin, 2011), by Imogen Evans, Hazel Thornton, Iain Chalmers, and Paul Glasziou (illustrated HTML at NIH)

• Clinical research as the basis of clinical practice (Center for Human Growth and Development, The University of Michigan, 1991), by Mich. : 1990) Symposium on Craniofacial Growth (17th : Ann Arbor and Katherine W. L. Vig (page images at HathiTrust)
• Chemoprevention clinical trials : problems and solutions (National Cancer Institute, 1985), by John G. Dell, Mary Ann Sestili, and National Cancer Institute (U.S.). Chemoprevention Branch (page images at HathiTrust)

• Clinical and Translational Science (full serial archives)

• Clinical Trials in Ovarian Cancer (New Brunswick, NJ et al.: Rutgers University Press, c2017), by Christine S. Walsh (PDF files with commentary at Project Muse)
• The Food and Drug Administration's process for approving new drugs : report (U.S. G.P.O. :, 1980), by Research United States. Congress. House. Committee on Science and Technology. Subcommittee on Science (page images at HathiTrust)
• New drug development in the United States (Dept. of Health & Human Services, Public Health Service, Food and Drug Administration, 1995), by United States Food and Drug Administration (page images at HathiTrust)
• Problems in securing informed consent of subjects in experimental trials of unapproved drugs and devices : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, second session, Washington, DC, May 23, 1994. (U.S. G.P.O. :, 1994), by Business Opportunities United States. Congress. House. Committee on Small Business. Subcommittee on Regulation (page images at HathiTrust)
• National Institute of Health clinical trials (The Office, 1999), by United States General Accounting Office (page images at HathiTrust)
• Clinical research : hearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Fourth Congress, second session, special hearing. (U.S. G.P.O. :, 1996), by Health and Human Services United States. Congress. Senate. Committee on Appropriations. Subcommittee on Departments of Labor (page images at HathiTrust)
• Women health care consumers : short-changed on medical research and treatment : hearing before the Subcommittee on Housing and Consumer Interests of the Select Committee on Aging, House of Representatives, One Hundred First Congress, second session, July 24 , 1990. (U.S. G.P.O. :, 1991), by United States. Congress. House. Select Committee on Aging. Subcommittee on Housing and Consumer Interests (page images at HathiTrust)
• Adequacy of access to investigative drugs for seriously ill patients : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, first session, September 23, 1997. (U.S. G.P.O. :, 1997), by United States House Committee on Commerce, Subcommittee on Oversight and Investigations (page images at HathiTrust)
• Assessment and treatment of patients with coexisting mental illness and alcohol and other drug abuse (U.S. Dept. of Health and Human Services, Public Health Service, Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment, 1994), by Richard Ries and Center for Substance Abuse Treatment (U.S.) (page images at HathiTrust)
• Proceedings : Fourth AIDS Clinical Trials Group Meeting, (National Institute of Allergy and Infectious Diseases, 1988), by Md.) AIDS clinical trials group meeting (4th : 1988 : Bethesda, United States. Dept. of Health and Human Services, and National Institute of Allergy and Infectious Diseases. AIDS Program (page images at HathiTrust)
• Clinical trials : how you can make the process more effective (U.S. Food and Drug Administration, 1996), by Pharmaceutical Research and Manufacturers of America, United States Food and Drug Administration, and Infectious Diseases Society of America (page images at HathiTrust)

More items available under broader and related terms at left.